Mortality and Cost Associated With Cardiovascular Implantable Electronic Device Infections

被引:255
|
作者
Sohail, Muhammad R. [1 ]
Henrikson, Charles A. [2 ]
Braid-Forbes, Mary Jo [3 ]
Forbes, Kevin F. [3 ,4 ]
Lerner, Daniel J. [5 ]
机构
[1] Mayo Clin, Div Infect Dis, Coll Med, Rochester, MN 55905 USA
[2] Johns Hopkins Univ, Div Cardiol, Baltimore, MD USA
[3] Braid Forbes Hlth Res, Silver Spring, MD USA
[4] Catholic Univ Amer, Washington, DC 20064 USA
[5] TYRX Inc, Monmouth Jct, NJ USA
关键词
DEFIBRILLATOR IMPLANTATION; MEDICARE BENEFICIARIES; AMERICAN-COLLEGE; HEART-FAILURE; UNITED-STATES; TASK-FORCE; MANAGEMENT; COMPLICATIONS; UPDATE; RATES;
D O I
10.1001/archinternmed.2011.441
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardiovascular implantable electronic device (CIED) therapy can reduce morbidity and mortality, but this benefit can be diminished by CIED infection. Currently, there are limited published data on the mortality and cost associated with CIED infection. Methods: We analyzed the risk-adjusted total and incremental admission mortality, long-term mortality, admission length of stay (LOS), and admission cost associated with infection in a retrospective cohort of 200 219 Medicare fee-for-service patients admitted for CIED generator implantation, replacement, or revision between January 1, 2007, and December 31, 2007. Results: There were a total of 5817 admissions with infection. Infection was associated with significant increases in adjusted admission mortality (rate ratios, 4.8-7.7; standardized rates, 4.6%-11.3%) and long-term mortality (rate ratios, 1.6-2.1; standardized rates, 26.5%-35.1%), depending on CIED type. Importantly, approximately half of the incremental long-term mortality occurred after discharge. The adjusted LOS was significantly longer with infection (length of stay mean ratios, 2.5-4.0; standardized length of stay, 15.5-24.3 days), depending on CIED type. The standardized adjusted incremental and total admission costs with infection were $14 360 to $16 498 and $28 676 to $53 349, respectively, depending on CIED type. The largest incremental cost with infection was intensive care, which accounted for more than 40% of the difference. Adjusted long-term mortality rate and cost ratios with infection were significantly greater for pacemakers than for implantable cardioverter/defibrillators or cardiac resynchronization therapy/defibrillator devices. Conclusions: Infection associated with CIED procedures resulted in substantial incremental admission mortality and long-term mortality that varied with the CIED type and occurred, in part, after discharge. Almost half of the incremental admission cost was for intensive care.
引用
收藏
页码:1821 / 1828
页数:8
相关论文
共 50 条
  • [1] Cardiovascular Implantable Electronic Device Associated Infections
    Gandhi, Tejal
    Crawford, Thomas
    Riddell, James
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2012, 26 (01) : 57 - +
  • [2] FINANCIAL COST AND MORTALITY ASSOCIATED WITH CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE INFECTIONS IN A CONTEMPORARY COHORT OF MEDICARE BENEFICIARIES
    Sohail, Muhammad R.
    Henrikson, Charles A.
    Braid-Forbes, Mary Jo
    Lerner, Daniel J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1234 - E1234
  • [3] Predictors of Mortality in Patients With Cardiovascular Implantable Electronic Device Infections
    Habib, Ammar
    Le, Katherine Y.
    Baddour, Larry M.
    Friedman, Paul A.
    Hayes, David L.
    Lohse, Christine M.
    Wilson, Walter R.
    Steckelberg, James M.
    Sohail, M. Rizwan
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (06): : 874 - 879
  • [4] Cardiovascular Implantable Electronic Device Infections
    Arnold, Christopher J.
    Chu, Vivian H.
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2018, 32 (04) : 811 - +
  • [5] Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections
    Le, Katherine Y.
    Sohail, Muhammad R.
    Friedman, Paul A.
    Uslan, Daniel Z.
    Cha, Stephen S.
    Hayes, David L.
    Wilson, Walter R.
    Steckelberg, James M.
    Baddour, Larry M.
    [J]. HEART RHYTHM, 2011, 8 (11) : 1678 - 1685
  • [6] Cardiovascular implantable electronic device infections: associated risk factors and prevention
    Rohacek, Martin
    Baddour, Larry M.
    [J]. SWISS MEDICAL WEEKLY, 2015, 145
  • [7] Procalcitonin in cardiovascular implantable electronic device infections
    Sedehi, D.
    Siddiqi, N.
    Shrestha, N.
    Agarwal, S.
    Tarakji, K.
    Wazni, O.
    Menon, V.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 100 - 100
  • [8] Increased Long-Term Mortality in Patients with Cardiovascular Implantable Electronic Device Infections
    Sohail, Muhammad Rizwan
    Henrikson, Charles A.
    Braid-Forbes, Mary Jo
    Forbes, Kevin F.
    Lerner, Daniel J.
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2015, 38 (02): : 231 - 239
  • [9] Comparison of Mortality in Women Versus Men With Infections Involving Cardiovascular Implantable Electronic Device
    Sohail, M. Rizwan
    Henrikson, Charles A.
    Braid-Forbes, Mary Jo
    Forbes, Kevin F.
    Lerner, Daniel J.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (09): : 1403 - 1409
  • [10] Differences of Mortality Rates between Pocket and Nonpocket Cardiovascular Implantable Electronic Device Infections
    Lee, Dong Heun
    Gracely, Edward J.
    Aleem, Sarah Y.
    Kutalek, Steven P.
    Vielemeyer, Ole
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2015, 38 (12): : 1456 - 1463